A new and simple method for HLA-B*5701 screening before abacavir treatment

被引：0
|
作者：
Bortolozzo, Katia [1 ]
Boschetto, Chiara [1 ]
Hajman, Karla [1 ]
Cesaro, Loretta [1 ]
Mason, Silvia [1 ]
Baroncelli, Marta [2 ]
Sestini, Roberta [2 ]
Porfirio, Berardino [2 ]
机构：
[1] AB ANALITICA srl, Padua, Italy
[2] Univ Florence, Florence, Italy
来源：
TISSUE ANTIGENS | 2010年 / 75卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：541 / 542
页数：2
相关论文
共 50 条
  • [1] Screening for HLA-B*5701 carriage before treatment by abacavir in reunion island
    Ricard, C.
    Ricaud, C.
    Poubeau, P.
    Gaud, C.
    [J]. TISSUE ANTIGENS, 2008, 71 (04): : 375 - 375
  • [2] HLA-B*5701 screening for hypersensitivity to abacavir
    Mallal, Simon
    Phillips, Elizabeth
    Carosi, Giampiero
    Molina, Jean-Michel
    Workman, Cassy
    Tomazic, Janez
    Jaegel-Guedes, Eva
    Rugina, Sorin
    Kozyrev, Oleg
    Cid, Juan Flores
    Hay, Phillip
    Nolan, David
    Hughes, Sara
    Hughes, Arlene
    Ryan, Susanna
    Fitch, Nicholas
    Thorborn, Daren
    Benbow, Alastair
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06): : 568 - 579
  • [3] HLA-B*5701 screening for hypersensitivity to abacavir
    Faruki, Hawazin
    Lai-Goldman, Myla
    [J]. PERSONALIZED MEDICINE, 2008, 5 (03) : 297 - 300
  • [4] HLA-B*5701 screening for susceptibility to abacavir hypersensitivity
    Lucas, Andrew
    Nolan, David
    Mallal, Simon
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) : 591 - 593
  • [5] From an Identified Risk to Regulatory Measures: Implementation of HLA-B★5701 Screening Before Abacavir Treatment
    N. Cachin
    C. Kreft-Jais
    [J]. Drug Safety, 2008, 31 (10) : 885 - 885
  • [6] HLA-B*5701 and abacavir hypersensitivity
    Watson, ME
    Pimenta, JM
    Spreen, WR
    Hernandez, JE
    [J]. PHARMACOGENETICS, 2004, 14 (11): : 783 - 784
  • [7] From an Identified Risk to Regulatory Measures: Implementation of HLA-B*5701 Screening Before Abacavir Treatment
    Cachin, N.
    Kreft-Jais, C.
    [J]. DRUG SAFETY, 2008, 31 (10) : 902 - 902
  • [8] Should HLA-B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?
    Park, Wan Beom
    Choe, Pyoeng Gyun
    Song, Kyoung-Ho
    Lee, Shinwon
    Jang, Hee-Chang
    Jeon, Jae Hyun
    Park, Sang-Won
    Park, Myoung Hee
    Oh, Myoung-don
    Choe, Kang Won
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (03) : 365 - 367
  • [9] Screening for HLA-B*5701 reduces the frequency of abacavir hypersensitivity reactions
    Reeves, I.
    Churchill, D.
    Fisher, M.
    [J]. ANTIVIRAL THERAPY, 2006, 11 (07) : L11 - L11
  • [10] HLA-B*5701 and abacavir hypersensitivity - Reply
    Hughes, D
    Park, BK
    Pirmohamed, M
    [J]. PHARMACOGENETICS, 2004, 14 (11): : 784 - 784
12345